Jeffrey Kahn, M.d., Ph.d.
UT Southwestern Medical Center
Jeffrey S. Kahn, M.D.-Ph.D. received his Bachelor of Science degree in Microbiology and Immunology from McGill University. He received his M.D. and a Ph.D. in Microbiology and Immunology from the State University of New York Health Science Center at Brooklyn. Dr. Kahn completed his internship, residency and chief residency in Pediatrics at Yale University and the Children’s Hospital at Yale-New Haven Hospital. Dr. Kahn stayed at Yale University to complete training in Pediatric Infectious Diseases. Thereafter, he joined the faculty at Yale University in the Department of Pediatrics in the Division of Infectious Diseases. He joined the faculty of UT Southwestern Medical Center in 2009.
Dr. Kahn’s research efforts have been focused human respiratory viruses, including respiratory syncytial virus (RSV) and new emerging human viruses. His laboratory was the first or among the first laboratories in the United States to describe the epidemiology and clinical manifestations of several newly identified viruses including human metapneumovirus, coronaviruses NL63 and HKU1, human bocavirus and polyomavirus WUV. His laboratory has described the molecular epidemiology of RSV and has characterized the glycoprotein sequences, completed phylogenetic analyses and defined the biological properties (e.g. induction of cytokines and chemokines) and induced gene expression profiles (using RNA-SEQ) of many of these RSV strains in primary human cells. Dr. Kahn’s current research efforts are focuses on mapping RSV phenotypes in the viral genome.